HomeComparePINC vs MRK

PINC vs MRK: Dividend Comparison 2026

PINC yields 1.49% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $31.8K in total portfolio value
10 years
PINC
PINC
● Live price
1.49%
Share price
$28.26
Annual div
$0.42
5Y div CAGR
16.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.0K
Annual income
$833.94
Full PINC calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PINC vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPINCMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PINC + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PINC pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PINC
Annual income on $10K today (after 15% tax)
$126.33/yr
After 10yr DRIP, annual income (after tax)
$708.85/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $7,619.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PINC + MRK for your $10,000?

PINC: 50%MRK: 50%
100% MRK50/50100% PINC
Portfolio after 10yr
$40.9K
Annual income
$5,316.04/yr
Blended yield
13.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PINC
Analyst Ratings
10
Buy
19
Hold
2
Sell
Consensus: Hold
Price Target
$28.25
-0.0% upside vs current
Range: $28.25 — $28.25
Altman Z
0.8
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PINC buys
0
MRK buys
0
No recent congressional trades found for PINC or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPINCMRK
Forward yield1.49%2.76%
Annual dividend / share$0.42$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR16.4%32.7%
Portfolio after 10y$25.0K$56.8K
Annual income after 10y$833.94$9,798.13
Total dividends collected$4.2K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$28.25$128.54

Year-by-year: PINC vs MRK ($10,000, DRIP)

YearPINC PortfolioPINC Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,873$172.99$11,206$366.19$333.00MRK
2$11,839$204.62$12,650$502.35$811.00MRK
3$12,910$242.37$14,407$694.19$1.5KMRK
4$14,101$287.51$16,585$967.82$2.5KMRK
5$15,430$341.63$19,342$1,363.89$3.9KMRK
6$16,916$406.66$22,913$1,947.19$6.0KMRK
7$18,586$485.01$27,662$2,823.89$9.1KMRK
8$20,466$579.68$34,159$4,173.35$13.7KMRK
9$22,593$694.42$43,337$6,308.80$20.7KMRK
10$25,009$833.94$56,776$9,798.13$31.8KMRK

PINC vs MRK: Complete Analysis 2026

PINCStock

Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services; STOCKD, an e-commerce platform; PROVIDEGX program, which identifies supply sources for drugs that are on or may be at risk of being added to the national drug shortage list, or that are vulnerable to pricing volatility, as well as direct sourcing business; SaaS informatics products; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company also provides services to other businesses, including food service, schools, and universities. Premier, Inc. was incorporated in 2013 and is headquartered in Charlotte, North Carolina.

Full PINC Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PINC vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PINC vs SCHDPINC vs JEPIPINC vs OPINC vs KOPINC vs MAINPINC vs JNJPINC vs ABBVPINC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.